Vtv Therapeutics

Entity > Corporation > US > New York City New York > Vtv Therapeutics

About vTv Therapeutics

vTv Therapeutics Inc. is a clinical-stage pharmaceutical company that is engaged in the discovery and development of orally administered small molecule drug candidates.

TTP399 Treats Type1 Diabetes: TTP399 completed the SimpliciT-I Study, a Phase II trial in patients with type I diabetes as an add-on to insulin therapy. TTP399 is an orally administered, small molecule, liver-selective glucokinase activator (GKA) in development potential oral anti-diabetic for the treatment of type I diabetes. It restores normal liver function when glucose levels are high: it traps glucose in liver cells, promotes further glucose uptake for energy production and storage, and keeps the liver in a "fed" state, preventing ketone production.

vTv Therapeutics Is Advancing Several Orally Administered Drugs: vTv Therapeutics is advancing HPP737, an orally administered, non- central nervous system (CNS) penetrant phosphodiesterase type 4 (PDE4) inhibitor that addresses inflammatory diseases. In addition, there is TTP273 which is an orally available, small molecule glucagon-like peptide 1 (GLP-1) receptor agonist focused on treating postprandial hyperglycemia in cystic fibrosis related diabetes (CFRD) patients and cystic fibrosis patients. Its products pipeline also includes the Nrf2/Bach1 Modulator Program.

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about vTv Therapeutics

Company Attribute Value
Name vTv Therapeutics
Url vtvtherapeutics
Google google
Wikidata wikidata

vTv Therapeutics


New York City, US
17 May 2024

New York City, US
17 May 2024

vTv Therapeutics

Page: 1 Desktop | Laptop Devices

VTV Therapeutics: Home
... in type 1 diabetes patients. To learn more about our science please visit our pipeline page. Contact Us · Twitter · linkedin. © Copyright 2024 VTV Therapeutics.
https://finance.yahoo.com › quote › VTVT
vTv Therapeutics Inc. (VTVT) Stock Price, News, Quote & ...
vTv Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on the development of orally administered treatments for metabolic and ...
vTv Therapeutics (@vTvTherapeutics) · X
https://www.wsj.com › Quotes
VTVT | vTv Therapeutics Inc. Cl A Stock Price & News
View the latest vTv Therapeutics Inc. Cl A (VTVT) stock price, news, historical charts, analyst ratings and financial information from WSJ.
https://www.marketwatch.com › ... › United States
VTVT Stock Price | vTv Therapeutics Inc. Cl A Stock Quote ...
VTVT | Complete vTv Therapeutics Inc. Cl A stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
https://www.biospace.com › employer › vtv-therapeutic...
Articles about vTv Therapeutics Inc.
(Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of an oral adjunctive therapy to insulin for the treatment of type 1 ...
vTv Therapeutics
vTv Therapeutics is a clinical stage biopharmaceutical company focused on developing oral, small molecule drug candidates. vTv has a pipeline of clinical ...
Related Searches
Related Searches
Vtv therapeutics news
vtv therapeutics reverse stock split
Vtv therapeutics stock prediction
Google My Business
Google My Business

vTv Therapeutics LLC (Pharmaceutical company in High Point, North Carolina)

  • Located in : Bank of North Carolina
  • Address : 3980 Premier Dr # 310, High Point, NC 27265
  • Phone : (336) 841-0300

Related Entities vTv Therapeutics

Entity Home Kalicube Pro Entity Page
vTv Therapeutics Entity Home vTv Therapeutics on Kalicube

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 193766